NewsBenzinga찰스 리버 래버러토리즈, 프론티지 홀딩스의 펜실베이니아 바이오분석 및 DMPK 사업부를 약 4억 7천만 달러 현금과 최대 7천 5백만 달러 추가 지급 조건으로 인수 찰스 리버 래버러토리즈, 프론티지 홀딩스의 펜실베이니아 바이오분석 및 DMPK 사업부를 약 4억 7천만 달러 현금과 최대 7천 5백만 달러 추가 지급 조건으로 인수 Benzinga 2026.11.09 11:19 (GMT+0) Open on Benzinga Other news Charles River Laboratories To Acquire Frontage Holdings Corporation’s Bioanalysis And DMPK Operations In Pennsylvania For ~$470M In Cash Plus Additional Payments Of Up To $75M HC Wainwright & Co. Assumes United Therapeutics at Buy, Announces Price Target of $660 Safe Harbor CEO Says Company Intends To Evaluate All Available Options, Including Further Reverse Stock Split, To Regain Nasdaq Minimum Bid Price Requirement BTIG Reiterates Buy on Boot Barn Holdings, Maintains $195 Price Target SHF Hldgs Q3 EPS $(0.95) Down From $0.72 YoY, Sales $1.952M Up From $1.834M YoY Greenfire Resources Q3 EPS $(0.11) Down From $(0.09) YoY, Sales $218.134M Up From $102.512M YoY
Charles River Laboratories To Acquire Frontage Holdings Corporation’s Bioanalysis And DMPK Operations In Pennsylvania For ~$470M In Cash Plus Additional Payments Of Up To $75M
Safe Harbor CEO Says Company Intends To Evaluate All Available Options, Including Further Reverse Stock Split, To Regain Nasdaq Minimum Bid Price Requirement
